{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:00:06Z","timestamp":1782975606534,"version":"3.54.5"},"reference-count":63,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ferritin nanocages with spherical shells carry proteins or antigens that enable their use as highly efficient nanoreactors and nanocarriers. Mimicking the surface Spike (S) receptor-binding domain (RBD) from SARS-CoV-2, ferritin nanocages induce neutralizing antibody production or block viral entry. Herein, by implementing molecular dynamics simulation, we evaluate the efficiency in the interaction pattern (active or alternative sites) of H-ferritin displaying the 24 S RBDs with host-cell-receptor or monoclonal antibodies (mAbs; B38 or VVH-72). Our constructed nanocage targeted the receptor- or antibody-binding interfaces, suggesting that mAbs demonstrate an enhanced binding affinity with the RBD, with key interactions originating from its variable heavy chain. The S RBD interactions with ACE2 and B38 involved the same binding site but led to divergent dynamic responses. In particular, both B38 chains showed that asymmetric fluctuations had a major effect on their engagement with the Spike RBD. Although the receptor increased the binding affinity of VVH-72 for the RBD, the mAb structural orientation on the nanocage remained identical to its conformation when bound to the host receptor. Overall, our findings characterize the essential pharmacophore formed by Spike RBD residues over nanocage molecules, which mediates high-affinity interactions with either binding partner. Importantly, the ferritin-displayed RBD maintained native receptor and antibody binding profiles, positioning it as a promising scaffold for pre-fusion stabilization and protective RBD vaccine design.<\/jats:p>","DOI":"10.3390\/ijms26157047","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T13:35:28Z","timestamp":1753191328000},"page":"7047","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ferritin Nanocages Exhibit Unique Structural Dynamics When Displaying Surface Protein"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-8620","authenticated-orcid":false,"given":"Monikaben","family":"Padariya","sequence":"first","affiliation":[{"name":"International Centre for Cancer Vaccine Science, University of Gdansk, ul. K\u0142adki 24, 80-822 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1201-295X","authenticated-orcid":false,"given":"Natalia","family":"Marek-Trzonkowska","sequence":"additional","affiliation":[{"name":"International Centre for Cancer Vaccine Science, University of Gdansk, ul. K\u0142adki 24, 80-822 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7757-6962","authenticated-orcid":false,"given":"Umesh","family":"Kalathiya","sequence":"additional","affiliation":[{"name":"International Centre for Cancer Vaccine Science, University of Gdansk, ul. K\u0142adki 24, 80-822 Gdansk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Martellucci, C.A., Flacco, M.E., Cappadona, R., Bravi, F., Mantovani, L., and Manzoli, L. (2020). SARS-CoV-2 Pandemic: An Overview. Adv. Biol. Regul., 77.","DOI":"10.1016\/j.jbior.2020.100736"},{"key":"ref_2","unstructured":"World Health Organization (2025) (2025, January 03). WHO Coronavirus Disease (COVID-19) Dashboard. Available online: https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2020.03.004","article-title":"The SARS-CoV-2 Outbreak: What We Know","volume":"94","author":"Wu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1085953","article-title":"The Genome Sequence of the SARS-Associated Coronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a Possible Cause of Severe Acute Respiratory Syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The Spike Protein of SARS-CoV\u2014A Target for Vaccine and Therapeutic Development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The Proximal Origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 Entry into Cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-59745-393-6_1","article-title":"Viruses and Glycosylation: An Overview","volume":"379","author":"Sugrue","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural Basis for the Recognition of SARS-CoV-2 by Full-Length Human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41392-020-00352-y","article-title":"A Systematic Review of SARS-CoV-2 Vaccine Candidates","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-Assembling Influenza Nanoparticle Vaccines Elicit Broadly Neutralizing H1N1 Antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Pati, R., Shevtsov, M., and Sonawane, A. (2018). Nanoparticle Vaccines against Infectious Diseases. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02224"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Reutovich, A.A., Srivastava, A.K., Arosio, P., and Bou-Abdallah, F. (2023). Ferritin Nanocages as Efficient Nanocarriers and Promising Platforms for COVID-19 and Other Vaccines Development. Biochim. Biophys. Acta Gen. Subj., 1867.","DOI":"10.1016\/j.bbagen.2022.130288"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Curley, S.M., and Putnam, D. (2022). Biological Nanoparticles in Vaccine Development. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.867119"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"199455","DOI":"10.1016\/j.virusres.2024.199455","article-title":"Eco-Friendly Synthesis of Silver Nanoparticles from Peel and Juice C. Limon and Their Antiviral Efficacy against HSV-1 and SARS-CoV-2","volume":"349","author":"Mosidze","year":"2024","journal-title":"Virus Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Anselmo, A.C., and Mitragotri, S. (2019). Nanoparticles in the Clinic: An Update. Bioeng. Transl. Med., 4.","DOI":"10.1002\/btm2.10143"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.partic.2021.04.020","article-title":"A Critical Review of Ferritin as a Drug Nanocarrier: Structure, Properties, Comparative Advantages and Challenges","volume":"64","author":"Yin","year":"2022","journal-title":"Particuology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nano.2006.07.009","article-title":"Adaptations of Nanoscale Viruses and Other Protein Cages for Medical Applications","volume":"2","author":"Lee","year":"2006","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Patra, J.K., Das, G., Fraceto, L.F., Campos, E.V.R., Rodriguez-Torres, M.D.P., Acosta-Torres, L.S., Diaz-Torres, L.A., Grillo, R., Swamy, M.K., and Sharma, S. (2018). Nano Based Drug Delivery Systems: Recent Developments and Future Prospects. J. Nanobiotechnol., 16.","DOI":"10.1186\/s12951-018-0392-8"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","article-title":"New Developments in Liposomal Drug Delivery","volume":"115","author":"Pattni","year":"2015","journal-title":"Chem. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Guo, S., Liu, J., Wang, Y., Wang, B., Peng, C., and Du, E. (2025). Adjuvant-Free, Self-Assembling Ferritin Nanoparticle Vaccine Coupled with Influenza Virus Hemagglutinin Protein Carrying M1 and PADRE Epitopes Elicits Cross-Protective Immune Responses. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1519866"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2018.02.042","article-title":"Ferritin-Based Drug Delivery Systems: Hybrid Nanocarriers for Vascular Immunotargeting","volume":"282","author":"Khoshnejad","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.nano.2016.03.007","article-title":"Biocompatibility of Ferritin-Based Nanoparticles as Targeted MRI Contrast Agents","volume":"12","author":"Charlton","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ahmadivand, S., Fux, R., and Pali\u0107, D. (2024). Ferritin Vaccine Platform for Animal and Zoonotic Viruses. Vaccines, 12.","DOI":"10.3390\/vaccines12101112"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ahmadivand, S., Krpetic, Z., Mart\u00ednez, M.M., Garcia-Ordo\u00f1ez, M., Roher, N., and Pali\u0107, D. (2024). Self-Assembling Ferritin Nanoplatform for the Development of Infectious Hematopoietic Necrosis Virus Vaccine. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1346512"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.nano.2013.11.003","article-title":"Ferritin Protein Cage Nanoparticles as Versatile Antigen Delivery Nanoplatforms for Dendritic Cell (DC)-Based Vaccine Development","volume":"10","author":"Han","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"eabi5735","DOI":"10.1126\/scitranslmed.abi5735","article-title":"A SARS-CoV-2 Ferritin Nanoparticle Vaccine Elicits Protective Immune Responses in Nonhuman Primates","volume":"14","author":"Joyce","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"eabq0839","DOI":"10.1126\/science.abq0839","article-title":"Mosaic RBD Nanoparticles Protect against Challenge by Diverse Sarbecoviruses in Animal Models","volume":"377","author":"Cohen","year":"2022","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/acscentsci.0c01405","article-title":"A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice","volume":"7","author":"Powell","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41541-022-00547-0","article-title":"CD4 T Cell Epitope Abundance in Ferritin Core Potentiates Responses to Hemagglutinin Nanoparticle Vaccines","volume":"7","author":"Nelson","year":"2022","journal-title":"NPJ Vaccines"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Padariya, M., and Kalathiya, U. (2024). Single Ferritin Nanocages Expressing SARS-CoV-2 Spike Variants to Receptor and Antibodies. Vaccines, 12.","DOI":"10.3390\/vaccines12050446"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kalathiya, U., Padariya, M., Fahraeus, R., Chakraborti, S., and Hupp, T.R. (2021). Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages. Biomolecules, 11.","DOI":"10.3390\/biom11020297"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e1703207","DOI":"10.1002\/smll.201703207","article-title":"Intranasal Nanovaccine Confers Homo- and Hetero-Subtypic Influenza Protection","volume":"14","author":"Qi","year":"2018","journal-title":"Small"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.str.2005.01.019","article-title":"Crystal Structures of a Tetrahedral Open Pore Ferritin from the Hyperthermophilic Archaeon Archaeoglobus Fulgidus","volume":"13","author":"Johnson","year":"2005","journal-title":"Structure"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A Noncompeting Pair of Human Neutralizing Antibodies Block COVID-19 Virus Binding to Its Receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cell.2020.05.047","article-title":"Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies","volume":"181","author":"Wrapp","year":"2020","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zhang, L., Ghosh, S.K., Basavarajappa, S.C., Muller-Greven, J., Penfield, J., Brewer, A., Ramakrishnan, P., Buck, M., and Weinberg, A. (2021). Molecular Dynamics Simulations and Functional Studies Reveal That hBD-2 Binds SARS-CoV-2 Spike RBD and Blocks Viral Entry into ACE2 Expressing Cells. Biorxivorg.","DOI":"10.1101\/2021.01.07.425621"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D Graphics Environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."},{"key":"ref_44","unstructured":"Loizides, F., and Schmidt, B. (2016). Jupyter Notebooks\u2014A publishing format for reproducible computational workflows. Positioning and Power in Academic Publishing: Players, Agents and Agendas, IOS Press."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tim.2007.03.003","article-title":"Virus Glycosylation: Role in Virulence and Immune Interactions","volume":"15","author":"Vigerust","year":"2007","journal-title":"Trends Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-021-00809-8","article-title":"The Glycosylation in SARS-CoV-2 and Its Receptor ACE2","volume":"6","author":"Gong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcdb.2014.12.001","article-title":"N-Linked Sugar-Regulated Protein Folding and Quality Control in the ER","volume":"41","author":"Tannous","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging WuHan (COVID-19) Coronavirus: Glycan Shield and Structure Prediction of Spike Glycoprotein and Its Interaction with Human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/rccm.202003-0541OC","article-title":"Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium","volume":"202","author":"Zhang","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Grant, O.C., Montgomery, D., Ito, K., and Woods, R.J. (2020). Analysis of the SARS-CoV-2 Spike Protein Glycan Shield Reveals Implications for Immune Recognition. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-71748-7"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1074\/mcp.M116.058016","article-title":"Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions","volume":"15","author":"Khatri","year":"2016","journal-title":"Mol. Cell. Proteom."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/jmbi.1997.0970","article-title":"Comparison of the Three-Dimensional Structures of Recombinant Human H and Horse L Ferritins at High Resolution","volume":"268","author":"Hempstead","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of Macromolecular Assemblies from Crystalline State","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and Scoring in Virtual Screening for Drug Discovery: Methods and Applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/ct900549r","article-title":"Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models","volume":"6","author":"Bjelkmar","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","article-title":"GROMACS 4.5: A High-Throughput and Highly Parallel Open Source Molecular Simulation Toolkit","volume":"29","author":"Pronk","year":"2013","journal-title":"Bioinformatics"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle Mesh Ewald: An N log(N) Method for Ewald Sums in Large Systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A Linear Constraint Solver for Molecular Simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"014101","DOI":"10.1063\/1.2408420","article-title":"Canonical Sampling through Velocity Rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic Transitions in Single Crystals: A New Molecular Dynamics Method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08927028808080941","article-title":"A Leap-Frog Algorithm for Stochastic Dynamics","volume":"1","author":"Berendsen","year":"1988","journal-title":"Mol. Simul."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Humphrey, W., Dalke, A., and Schulten, K. (1996). VMD: Visual Molecular Dynamics. J. Mol. Graph., 14.","DOI":"10.1016\/0263-7855(96)00018-5"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure Visualization for Researchers, Educators, and Developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7047\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:13:57Z","timestamp":1760033637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":63,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157047"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157047","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]}}}